BAYER AKTIENGESELLSCHAFT from 14/10/2019 to 14/10/2019 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 14/10/2019 16:09 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients Register number: 282563